FindTrial
Sign In

Endoscopic submucosal dissection (ESD) VS.endoscopic mucosal resection with a ligating device (EMR-L) for small rectal neuroendocrine tumors (NET) less than 1 cm: a randomized controlled trial.

Endoscopic submucosal dissection (ESD) VS.endoscopic mucosal resection with a ligating device (EMR-L) for small rectal neuroendocrine tumors (NET) less than 1 cm: a randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022524
Enrollment
Unknown
Registered
2019-04-15
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuroendocrine neoplasm

Interventions

ESD group:Tumor resected by ESD
EMR-L group:Tumor resected by EMR-L

Sponsors

Shandong Provincial Hospital Affiliated to Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged older than 18 years Chinese patient; 2. Suspected rectal NET confirmed by colonoscopy or EUS; 3. The tumor was limited to mucosal or submucosal layer and less than 1 cm; 4. The patients sign the inform consent and received the treatment.

Exclusion criteria

Exclusion criteria: 1. Metastasis was confirmed by preoperative examination; 2. The patient could not tolerate the treatment.

Design outcomes

Primary

MeasureTime frame
R0 resection rate;recurrence and metastasis;—

Secondary

MeasureTime frame
operation time;complication rate;—

Countries

China

Contacts

Public ContactYongjun Shi
shyjxfj@sina.com+86 0531-68773293

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026